(Q54648845)

English

Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers.

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Characterization of immune cell subsets during the active phase of multiple sclerosis reveals disease and c-Jun N-terminal kinase pathway biomarkers. (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

multiple sclerosis

0 references

0 references

10

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

11

object named as

Giancarlo Comi

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

author name string

Chiara Ferrandi

1

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Fabien Richard

2

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Patrizia Tavano

3

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Ehud Hauben

4

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Valerie Barbié

5

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Jean-Pierre Gotteland

6

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Beatrice Greco

7

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Mara Fortunato

8

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Maurizio F Mariani

9

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Gianvito Martino

12

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Paola F Zaratin

13

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

publication date

20 September 2010

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Multiple Sclerosis Journal

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

17

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

1

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

43-56

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Prevention of autoimmune attack and disease progression in multiple sclerosis: current therapies and future prospects

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Exacerbation of experimental autoimmune encephalomyelitis in P2X7R-/- mice: evidence for loss of apoptotic activity in lymphocytes

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Experimental autoimmune encephalomyelitis in the Wistar rat: dependence of MBP-specific T cell responsiveness on B7 costimulation

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Apoptotic and effector pathways in autoimmunity

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Blood transcriptional signatures of multiple sclerosis: unique gene expression of disease activity

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Expression ratios of the Bcl-2 family proteins and disease activity in multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

How MAP kinases are regulated

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

The c-Jun N-terminal protein kinase family of mitogen-activated protein kinases (JNK MAPKs).

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Experimental Autoimmune Demyelination: Chronic Relapsing Models and Their Therapeutic Implications for Multiple Sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Activation of mitogen-activated protein kinases in experimental autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

The JNK pathway regulates the In vivo deletion of immature CD4(+)CD8(+) thymocytes

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Differentiation of CD4+ T cells to Th1 cells requires MAP kinase JNK2.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

c-Jun NH(2)-terminal kinase (JNK)1 and JNK2 have distinct roles in CD8(+) T cell activation

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Molecular basis of T-cell differentiation

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Signaling and cell death in lymphocytes

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Design and synthesis of the first generation of novel potent, selective, and in vivo active (benzothiazol-2-yl)acetonitrile inhibitors of the c-Jun N-terminal kinase.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

The activation of memory CD4(+) T cells and CD8(+) T cells in patients with multiple sclerosis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

CD4 T cell activation and disease activity at onset of multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Biological markers of interferon-beta therapy: comparison among interferon-stimulated genes MxA, TRAIL and XAF-1.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Multiple sclerosis, natalizumab therapy, and progressive multifocal leukoencephalopathy

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Inhibition of Smad7, a negative regulator of TGF-beta signaling, suppresses autoimmune encephalomyelitis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

The Notch regulator Numb links the Notch and TCR signaling pathways

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Modulating CCR2 and CCL2 at the blood-brain barrier: relevance for multiple sclerosis pathogenesis

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

OAS1 gene haplotype confers susceptibility to multiple sclerosis.

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Vascular endothelial growth factor (VEGF) in autoimmune diseases

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Th17: the third member of the effector T cell trilogy

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Th17 cells: effector T cells with inflammatory properties

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

IL-19 and IL-20: two novel cytokines with importance in inflammatory diseases

1 reference

https://api.crossref.org/works/10.1177%2F1352458510381258

21 January 2018

Identifiers

10.1177/1352458510381258

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 June 2018

http://europepmc.org/abstract/MED/20855355

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q54648845&oldid=1002953773"